NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
Stevenage, United Kingdom Saturday, January 10, 2026, 14:00 Hrs [IST] ...
When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the ...
NRG5051 is a first-in-class, orally bioavailable and CNS-penetrant next-generation inhibitor of the mitochondrial permeability transition pore (mPTP), acting through a novel undisclosed ...
News-Medical.Net on MSN
Neural pain pathways found to play crucial role in bone fracture healing
When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the ...
Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...
Encephalitis is an inflammation of the brain that can be caused by infections or autoimmune reactions. Even when patients survive the acute phase, many are left with long-lasting neurological problems ...
Morning Overview on MSN
New cell discovery may explain how Alzheimer’s spreads through the brain
Alzheimer’s disease has long looked like a slow-motion wildfire, starting in one part of the brain and then advancing along ...
Alzheimer’s disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows ...
EG110A is a non-replicating HSV-1 vector designed to selectively silence the signals of type C sensory neurons responsible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback